Monopar Therapeutics MNPR Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Monopar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monopar Therapeutics's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Monopar Therapeutics's total operating expenses?
- Monopar Therapeutics (MNPR) reported total operating expenses of $5.23M in Q1 2026.
- How has Monopar Therapeutics's total operating expenses changed year-over-year?
- Monopar Therapeutics's total operating expenses increased by 62.2% year-over-year, from $3.22M to $5.23M.
- What is the long-term trend for Monopar Therapeutics's total operating expenses?
- Over 4 years (2021 to 2025), Monopar Therapeutics's total operating expenses has grown at a 16.3% compound annual growth rate (CAGR), from $9.13M to $16.7M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.